Mangoceuticals (MGRX) Short-term Investments (2023 - 2026)

Mangoceuticals (MGRX) has 4 years of Short-term Investments data on file, last reported at $16957.0 in Q1 2026.

• For the quarter ending Q1 2026, Short-term Investments changed 0.09% year-over-year to $16957.0; the trailing twelve-month figure through Mar 2026 stood at $16957.0 (changed 0.09% YoY), and the FY2025 full-year result was $33899.0, up 100.09% from the prior year.
• Short-term Investments retreated to $16957.0 in Q1 2026, from $33899.0 in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $33899.0 in Q4 2025 to a low of $16942.0 in Q4 2023.
• A 4-year average of $19063.5 and a median of $16942.0 in 2023 frame the typical range for Short-term Investments.
• Across the five-year window, Short-term Investments changed 0.0% in 2024 and surged 100.09% in 2025, its largest moves.
• Tracing MGRX's Short-term Investments over 4 years: stood at $16942.0 in 2023, then changed by 0.0% to $16942.0 in 2024, then surged by 100.09% to $33899.0 in 2025, then plunged by 49.98% to $16957.0 in 2026.
• Business Quant data shows MGRX's Short-term Investments at $16957.0 in Q1 2026, $33899.0 in Q4 2025, and $16942.0 in Q3 2025.